Dyadic International Inc. Insider Trading

DYAI

⊜ Compare

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Aug 2025.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

Aug 2025

Aug 1, 2025

Get an email when DYAI's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jul 22 – 24	Francisco Trust Under Agreement Dated February 28, 1996 Large holder	SoldNo plan 3 parts	95,392	$1.31 average	125K	2.8%	Form 4
Aug 1, 2025	Joseph P Hazelton President and COO	Bought	26,000	$0.95	25K	20%	Form 4
Dec 20, 2024 – Jan 7, 2025	Francisco Trust Under Agreement Dated February 28, 1996 Large holder	SoldNo plan 6 parts	146,524	$1.91 average	280K	4.2%	Form 4

Jul 22 – 24No plan
Francisco Trust Under Agreement Dated February 28, 1996
Large holder · sold 95,392 at avg $1.31
125K
2.8% of stake
Aug 1, 2025
Joseph P Hazelton
President and COO · bought 26,000 at $0.95
25K
20% of stake
Dec 20, 2024 – Jan 7, 2025No plan
Francisco Trust Under Agreement Dated February 28, 1996
Large holder · sold 146,524 at avg $1.91
280K
4.2% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch DYAI, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with DYAI

CompareIntrinsic value

ALGSAligos Therapeutics Inc.

$5.02+5.68%10

CRISCuris Inc.

$1.11+56.34%25

OCGNOcugen Inc.

$0.88+17.45%40

PRMEPrime Medicine Inc.

$4.97+9.23%0

DBVTDBV Technologies S.A.

$9.94-1.68%10

HUMAHumacyte, Inc.

$0.45+2.04%10

TSHATaysha Gene Therapies Inc.

$4.36+6.60%40

OTLKOutlook Therapeutics Inc.

$0.46+0.46%10

Spot a number that looks wrong? Check it in DYAI's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing DYAI

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.